Journal profile · PHARMACOLOGY & PHARMACY
Current Reviews in Clinical and Experimental Pharmacology
ISSN 2772-4328 · eISSN 2772-4336 · Bentham
Current Reviews in Clinical and Experimental Pharmacology: CAS Zone 4 · Medicine (2025 upgraded edition); hybrid open access; median 113 days to acceptance (40 articles, last 24 months); 24 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Current Reviews in Clinical and Experimental Pharmacology is published by Bentham and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmacogenetics and Drug Metabolism, Pharmaceutical studies and practices and Antibiotics Pharmacokinetics and Efficacy, together about 24.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): PHARMACOLOGY & PHARMACY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics11.1%
- Pharmaceutical studies and practicesMedicine7.5%
- Antibiotics Pharmacokinetics and EfficacyMedicine5.6%
- Anesthesia and Pain ManagementMedicine5.4%
- Anesthesia and Sedative AgentsMedicine5.1%
- Statistical Methods in Clinical TrialsMathematics4.5%
- Pharmaceutical Practices and Patient OutcomesMedicine4.1%
- Drug Transport and Resistance MechanismsMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| General Pharmacology, Toxicology and Pharmaceutics | Q2 | 22/79 | 72nd |
| Pharmacology (medical) | Q2 | 131/278 | 53rd |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 4.1LetPub ·
- SJR 2026-06
- 0.55LetPub ·
- SNIP 2026-06
- 0.81LetPub ·
- h-index
- 57OpenAlex ·
- i10-index
- 336OpenAlex ·
- 2-year mean citedness
- 2.6OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 5.88%LetPub ·
Volume
- Articles per year
- 19LetPub ·
Articles by year OpenAlex count · 758 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 22 | 0 | 701 |
| 2025 | 24 | 2 | 1,125 |
| 2024 | 34 | 3 | 1,170 |
| 2023 | 17 | 2 | 1,155 |
| 2022 | 37 | 3 | 1,159 |
| 2021 | 52 | 11 | 1,165 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
113 daysMedian, submission to acceptance · P25–P75 95 days – 139 days
- Acceptance to online
- median 127 days (40 articles)
- Submission to online
- median 231 days
- Sample
- 40 articles with submission and acceptance dates (77 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Bentham
- ISSN
- 2772-4328
- Electronic ISSN
- 2772-4336
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Current Reviews in Clinical and Experimental Pharmacology
What CAS zone is Current Reviews in Clinical and Experimental Pharmacology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Reviews in Clinical and Experimental Pharmacology is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Current Reviews in Clinical and Experimental Pharmacology?
Based on the dates recorded on 40 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 113 days (interquartile range 95–139 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Current Reviews in Clinical and Experimental Pharmacology?
According to LetPub and DOAJ records, Current Reviews in Clinical and Experimental Pharmacology is indexed in ESCI and Scopus.
Is Current Reviews in Clinical and Experimental Pharmacology open access, and what is the APC?
Current Reviews in Clinical and Experimental Pharmacology is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .